(Nasdaq: ACOG) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company focused on developing novel therapies for debilitating neurodegenerative disorders, today announced the appointment of ...

Alpha Cognition Inc. is a commercial stage, biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer’s disease and ...

Fintel reports that on April 17, 2026, Craig-Hallum initiated coverage of Alpha Cognition (NasdaqCM:ACOG) with a Buy recommendation. Analyst Price Forecast Suggests 169.21% Upside As of April 14, 2026 ...

VANCOUVER, British Columbia & GRAPEVINE, Texas--(BUSINESS WIRE)-- Alpha Cognition Inc. (ACOG) (“Alpha Cognition,” “ACI,” or the “Company”), a clinical ...

VANCOUVER, British Columbia--(BUSINESS WIRE)--Alpha Cognition Inc. (TSX-V: ACOG) (OTCQB: ACOGF) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company committed to developing novel ...

VANCOUVER, British Columbia & GRAPEVINE, Texas--(BUSINESS WIRE)-- Alpha Cognition Inc. (NASDAQ: ACOG) (“Alpha Cognition”, “ACI”, or the “Company”), a ...

VANCOUVER, British Columbia & DALLAS--(BUSINESS WIRE)-- Alpha Cognition Inc. (Nasdaq: ACOG) (“Alpha Cognition” [ACI], or the “Company”), a biopharmaceutical ...

Alpha Cognition Inc. Common Stock (NASDAQ:ACOG) Q1 2025 Earnings Call Transcript May 15, 2025 Operator: Greetings and welcome to the Alpha Cognition earnings call. At this time, all participants are ...

Alpha Cognition (NASDAQ:ACOG – Get Free Report) is one of 300 publicly-traded companies in the “Biological products, except diagnostic” industry, but how does it weigh in compared to its competitors?

Detailed price information for Alpha Cognition Inc (ACOG-Q) from The Globe and Mail including charting and trades.

Link to Register: https://us06web.zoom.us/webinar/register/WN_5W_rY9BrSZ2eqv3dp_FqoQ About Alpha Cognition Inc. Alpha Cognition Inc. is a commercial stage ...